NCT02264015View on ClinicalTrials.gov

Pharmacodynamic Effects, Safety and Tolerability of Cilobradine, to Healthy Male and Female Volunteers, With an Intra-individual Comparison to Moxifloxacin in a Subset of Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

125

Participants

Timeline

Start Date

January 31, 2004

Primary Completion Date

May 31, 2004

Conditions
Healthy
Interventions
DRUG

Cilobradine, low, film-coated tablets

DRUG

Cilobradine, high, film-coated tablets

DRUG

Placebo, film-coated tablets

DRUG

Moxifloxacin, film-coated tablets

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY